|
55
|
223
|
5eg4A |
Bovine trypsin in complex with cyclic inhibitor |
|
49
|
238
|
5e2oA |
Factor xia in complex with the inhibitor 4-[(n-{(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}-l-phenylalanyl)amino]benzoic acid |
|
53
|
237
|
5exnA |
Factor xia (c500s [c122s]) in complex with the inhibitor methyl ~{n}-[4-[2-[(1~{s})-1-[[(~{e})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate |
|
52
|
234
|
4zaeA |
Development of a novel class of potent and selective fixa inhibitors |
|
46
|
198
|
5eqrA |
Crystal structure of a genotype 1a/3a chimeric hcv ns3/4a protease in complex with danoprevir |
|
48
|
238
|
5ejlA |
Mrkh, a novel c-di-gmp dependence transcription regulatory factor. |
|
36
|
174
|
5e0jA |
1.20 a resolution structure of norovirus 3cl protease in complex with a triazole-based macrocyclic (21-mer) inhibitor |
|
40
|
175
|
5e0gA |
1.20 a resolution structure of norovirus 3cl protease in complex with a triazole-based macrocyclic (17-mer) inhibitor |
|
61
|
208
|
5dsfA |
Crystal structure of the mercury-bound form of merb mutant d99s |
|
41
|
181
|
5dp3A |
Crystal structure of ev71 3c proteinase in complex with compound 2 |
|
41
|
178
|
5dp6A |
Crystal structure of ev71 3c proteinase in complex with compound 7 |
|
41
|
175
|
5dgjA |
1.0a resolution structure of norovirus 3cl protease in complex an oxadiazole-based, cell permeable macrocyclic (20-mer) inhibitor |
|
39
|
181
|
5dp7A |
Crystal structure of ev71 3c proteinase in complex with compound 5 |
|
41
|
181
|
5dp8A |
Crystal structure of ev71 3c proteinase in complex with compound 8 |
|
40
|
181
|
5dp5A |
Crystal structure of ev71 3c proteinase in complex with compound 4 |
|
56
|
230
|
5dj7A |
S. erythraea trypsin acyl-enzyme |
|
37
|
181
|
5dpaA |
Crystal structure of ev71 3c proteinase in complex with compound 6 |
|
59
|
230
|
5dkmA |
S. erythraea trypsin michaelis-menten complex |
|
41
|
181
|
5dp4A |
Crystal structure of ev71 3c proteinase in complex with compound 3 |
|
59
|
230
|
5dk1A |
S. erythraea trypsin mixed catalytic intermediate |
|
34
|
174
|
5dg6A |
2.35a resolution structure of norovirus 3cl protease in complex an oxadiazole-based, cell permeable macrocyclic (21-mer) inhibitor |
|
61
|
254
|
4yt6H |
Factor viia in complex with the inhibitor 4-{[(r)-[5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl](4-phenyl-1h-imidazol-2-yl)methyl]amino}benzenecarboximidamide |
|
56
|
258
|
5ahgH |
Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine |
|
51
|
235
|
4yzuA |
Rapid development of two factor ixa inhibitors from hit to lead |
|
66
|
259
|
4yesB |
Thrombin in complex with (s)-(4-chloro-2-((1-(5-methyl-1h-pyrrole-2-carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium |
|
84
|
306
|
4yo9A |
Hku4 3clpro unbound structure |
|
54
|
223
|
4ytaA |
Bond length analysis of asp, glu and his residues in trypsin at 1.2a resolution |
|
64
|
249
|
4ylqH |
Crystal structure of a fviia-trypsin chimera (ft) in complex with soluble tissue factor |
|
81
|
304
|
4yluA |
X-ray structure of mers-cov nsp5 protease bound with a non-covalent inhibitor |
|
52
|
238
|
4y8yA |
Factor xia in complex with the inhibitor methyl (4-{4-chloro-2-[(1s)-1-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-3-(morpholin-4-yl)-3-oxopropyl]-1h-imidazol-5-yl}phenyl)carbamate |
|
13
|
131
|
5chaB |
The refinement and the structure of the dimer of alpha-*chymotrypsin at 1.67-*angstroms resolution |
|
19
|
97
|
5chaC |
The refinement and the structure of the dimer of alpha-*chymotrypsin at 1.67-*angstroms resolution |
|
60
|
234
|
4y76A |
Factor xa complex with gtc000401 |
|
59
|
257
|
5afyH |
Thrombin in complex with 3-chloro-benzamide |
|
13
|
84
|
5chbA |
Crystal structure of nvpizza2-s16h58 coordinating a cdcl2 nanocrystal |
|
56
|
238
|
4y8xA |
Factor xia in complex with the inhibitor methyl (4-{4-chloro-2-[(1s)-1-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-phenylethyl]-1h-imidazol-5-yl}phenyl)carbamate |
|
59
|
257
|
5afzH |
Thrombin in complex with (2r)-2-(benzylsulfonylamino)-n-(2-((4- carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl-propanamide |
|
53
|
238
|
4y8zA |
Factor xia in complex with the inhibitor (2e)-n-[(1s)-1-[5-chloro-4-(4-hydroxy-2-oxo-1,2-dihydroquinolin-6-yl)-1h-imidazol-2-yl]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enamide |
|
56
|
241
|
4xdeA |
Coagulation factor xii protease domain crystal structure |
|
61
|
234
|
4y7bA |
Factor xa complex with gtc000441 |
|
59
|
223
|
4y0zE |
Trypsin in complex with with bpti mutant aminobutyric acid |
|
46
|
238
|
4xe4A |
Coagulation factor xii protease domain crystal structure |
|
57
|
223
|
4y0yE |
Trypsin in complex with with bpti |
|
60
|
234
|
4y71A |
Factor xa complex with gtc000398 |
|
58
|
223
|
4xojA |
Structure of bovine trypsin in complex with analogues of sunflower inhibitor 1 (sfti-1) |
|
61
|
234
|
4y79A |
Factor xa complex with gtc000406 |
|
57
|
223
|
4y11E |
Trypsin in complex with with bpti mutant (2s)-2-amino-4,4,4-trifluorobutanoic acid |
|
40
|
175
|
4xbdA |
1.45a resolution structure of norovirus 3cl protease complex with a covalently bound dipeptidyl inhibitor (1r,2s)-2-({n-[(benzyloxy)carbonyl]-3-cyclohexyl-l-alanyl}amino)-1-hydroxy-3-[(3s)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid (orthorhombic p form) |
|
57
|
246
|
4xskU |
Structure of paitrap, an upa mutant |
|
64
|
234
|
4y6dA |
Factor xa complex with gtc000101 |
